| 000 | 01504 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513134712.0 | ||
| 264 | 0 | _c19980402 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a1064-7481 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCaligiuri, M P | |
| 245 | 0 | 0 |
_aExtrapyramidal side effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication. _h[electronic resource] |
| 260 |
_bThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry _c1998 |
||
| 300 |
_a75-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBasal Ganglia Diseases _xchemically induced |
| 650 | 0 | 4 | _aCalifornia |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHaloperidol _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aThioridazine _xadverse effects |
| 700 | 1 | _aRockwell, E | |
| 700 | 1 | _aJeste, D V | |
| 773 | 0 |
_tThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry _gvol. 6 _gno. 1 _gp. 75-82 |
|
| 999 |
_c9438164 _d9438164 |
||